phone icon  Toll Free : +1-800-792-5285 | (UK) : + 44-845-528-1300
Allied Market Research

0
Shopping Cart is Empty..
$ 0
CART  yellow arrow
 

Animal Vaccines Market Overview:

Global Animal Vaccines Market is expected to garner $9,159 million by 2022, registering a CAGR of 5.2% during the forecast period 2016 - 2022. Animal vaccines control the transmission diseases, thus providing protection to animal and human health, which is essential considering the public dependency on animals. Animals serve as an important source of food, meat, milk, protein, and other commercial products such as leather and wool. Most commonly used veterinary vaccines include rabies vaccines, foot & mouth diseases vaccines, and equine influenza virus vaccines, which prevent the transmission of infectious agents by mimicking the naturally acquired immunity. Constant development of vaccines is essential with rise in emergence of different animal diseases. Increase in pet ownership has significantly accelerated the growth of this market.

Global Animal Vaccines Market Segmentation

Animal Vaccines Market Segmentation

The animal vaccines market is segmented on the basis of product type, animal type, and geography. By product type, the market is categorized into attenuated vaccines, inactivated vaccines, subunit vaccines, toxoid vaccines, conjugate vaccines, recombinant vaccines, and DNA vaccines. Based on animal type, it is classified into companion animals, cattle, pigs, poultry, and sheep. The companion animals segment is subsegmented into dogs, cats, and others. Geographically, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The animal vaccines market is growing at a steady pace due to increase in pet ownership in developed countries and rise in number of cattle & poultry in developing countries. Furthermore, rise in investment for R&D of vaccines, which inhibit the growth of antibiotic-resistant organisms boosts the market growth. For instance, in August 2016, Elanco invested two-thirds of the budget for foodanimal unit to develop vaccines and reduce the use of antibiotics. Moreover, rise in demand for animal vaccines has led to the emergence of multiple new vaccines. For instance, Cevac IBron a new vaccine was launched by Ceva in February 2017 that prevents against infectious bronchitis virus (IBV).

The key players profiled in this report include Merck & Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Romvac, Vaxxinova, Biovac, Merial, and Anicon Labor GmbH.

Other players operating in the market are Nexvet, PHL Associates, Inc., Hygieia Biological Laboratories, Colorado Serum Company, Pfizer, and Arko Laboratories, Ltd.

Global Animal Vaccines Market Revenue, By Geography

Animal Vaccines Market Revenue By Geography

Asia-Pacific possesses high market potential for animal vaccines due to increase in pet ownership and rise in incidence of various zoonotic diseases. Moreover, ongoing research on innovative vaccine production technology has increased due to high demand for animal-based food products and companion animals. In addition, increase in investments in animal healthcare companies has improved the production of innovative vaccines.

Saudi Arabia Animal Vaccines Market, 2014-2022 ($Million)

Saudi Arabia Animal Vaccines Market

The animal vaccines market in Saudi Arabia is projected to grow at a high CAGR of 7.3% during the forecast period. In addition, the U.S. is a mature market for the animal vaccines, as it holds maximum share in the patent registration for animal vaccines. However, Asia-Pacific is experiencing fast-paced growth in terms of production and development of animal vaccines.

Animal Vaccines Market Key Benefits

  • The report provides an extensive analysis of the current trends and highlights the market potential from 2014 to 2022, in terms of value.
  • The market scenario is comprehensively analyzed with respect to the product type and animal type.
  • Comprehensive analysis of the patents is provided to determine the prevailing opportunities.
  • Recent developments, key manufacturers, and shares are listed in this report to analyze the competitive scenario of the market.
  • In-depth geographical analysis helps to understand the regional market, which assists in strategic business planning.

Animal Vaccines Market Key Segments

By Product

  • Attenuated Vaccines
  • Inactivated Vaccines
  • Subunit Vaccines
  • Toxoid Vaccines
  • Conjugate Vaccines
  • Recombinant Vaccines
  • DNA Vaccines

By Animal Type

  • Companion Animals
    • Dogs
    • Cats
    • Others
  • Cattle
  • Pigs
  • Poultry
  • Sheep

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Australia
    • India
    • South Korea
    • Taiwan
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Turkey
    • Venezuela
    • Saudi Arabia
    • Rest of LAMEA

Enquiry About Report

Let us know more about your research need and we will customize an offer exclusively for you!

Please input above shown text into input box
or click refresh

* Pricing on the website is provided for single users licenses only. All reports will be provided in a PDF format for download. To purchase multi-user licenses, please contact us at +1-800-792-5285 or send an email to sales@alliedmarketresearch.com

Chapter: 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

Chapter: 2 EXECUTIVE SUMMARY

2.1. CXO Perspective

Chapter: 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets

3.3. GOVERNMENT REGULATIONS

3.3.1. Center for Veterinary Biologics(CVB)

3.4. PATENTS ANALYSIS

3.4.1. PATENT ANALYSIS BY YEAR
3.4.2. PATENT ANALYSIS BY REGION

3.5. MARKET DYNAMICS

3.5.1. Drivers

3.5.1.1. Rising demand for animal derived food products
3.5.1.2. Growing demand for pet insurance
3.5.1.3. Rising concern to prevent zoonotic diseases
3.5.1.4. Growing ownership of companion animals
3.5.1.5. Rising animal health expenditure

3.5.2. Restraints

3.5.2.1. Highly competitive meat and milk prices
3.5.2.2. Lack of animal health awareness
3.5.2.3. Adverse impact of veterinary vaccines on human and animal health

3.5.3. Opportunities

3.5.3.1. Advancement in vaccine products
3.5.3.2. Vaccine products for hybrid animals

Chapter: 4 ANIMAL VACCINES MARKET, BY TYPE

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. ATTENUATED VACCINES

4.2.1. Key market trends
4.2.2. Key growth factors and opportunities
4.2.3. Market size and forecast

4.3. INACTIVATED VACCINES

4.3.1. Key market trends
4.3.2. Key growth factors and opportunities
4.3.3. Market size and forecast

4.4. SUBUNIT VACCINES

4.4.1. Key market trends
4.4.2. Key growth factors and opportunities
4.4.3. Market size and forecast

4.5. TOXOID VACCINES

4.5.1. Key market trends
4.5.2. Key growth factors and opportunities
4.5.3. Market size and forecast

4.6. CONJUGATE VACCINES

4.6.1. Key market trends
4.6.2. Key growth factors and opportunities
4.6.3. Market size and forecast

4.7. RECOMBINANT VACCINES

4.7.1. Key market trends
4.7.2. Key growth factors and opportunities
4.7.3. Market size and forecast

4.8. DNA VACCINES

4.8.1. Key market trends
4.8.2. Key growth factors and opportunities
4.8.3. Market size and forecast

Chapter: 5 ANIMAL VACCINES MARKET, BY ANIMAL TYPE

5.1. OVERVIEW
5.2. COMPANION ANIMALS

5.2.1. Market size and forecast
5.2.2. Dogs
5.2.3. Cats
5.2.4. Other Companion Animals

5.3. CATTLE

5.3.1. Market size and forecast

5.4. PIGS

5.4.1. Market size and forecast

5.5. POULTRY

5.5.1. Market size and forecast

5.6. SHEEP

5.6.1. Market size and forecast

Chapter: 6 ANIMAL VACCINES MARKET, BY GEOGRAPHY

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. NORTH AMERICA

6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.4. U.S. market size & forecast
6.2.5. Canada market size & forecast
6.2.6. Mexico market size & forecast

6.3. EUROPE

6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.4. Germany market size & forecast
6.3.5. France market size & forecast
6.3.6. UK market size & forecast
6.3.7. Italy market size & forecast
6.3.8. Rest of Europe market size and forecast

6.4. ASIA-PACIFIC

6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.4. Japan market size & forecast
6.4.5. China market size & forecast
6.4.6. Australia market size & forecast
6.4.7. India market size & forecast
6.4.8. South Korea market size & forecast
6.4.9. Taiwan market size & forecast
6.4.10. Rest of Asia-Pacific market size and forecast

6.5. LAMEA

6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.4. Brazil market size & forecast
6.5.5. Turkey market size & forecast
6.5.6. Venezuela market size & forecast
6.5.7. Saudi Arabia market size & forecast
6.5.8. Rest of LAMEA market size and forecast

Chapter: 7 COMPANY PROFILES

7.1. MERCK & CO., INC.

7.1.1. Company overview
7.1.2. Operating business segments
7.1.3. Business performance
7.1.4. Key strategic moves & developments

7.2. ZOETIS INC.

7.2.1. Company overview
7.2.2. Operating business segments
7.2.3. Business performance
7.2.4. Key strategic moves & developments

7.3. CEVA SANTÉ ANIMALE

7.3.1. Company overview
7.3.2. Operating business segments
7.3.3. Business performance

7.4. SANOFI S.A.

7.4.1. Company overview
7.4.2. Business performance
7.4.3. Key strategic moves & developments

7.5. ROMVAC

7.5.1. Company overview
7.5.2. Operating business segments
7.5.3. Business performance

7.6. VAXXINOVA

7.6.1. Company overview
7.6.2. Operating business segments
7.6.3. Business performance

7.7. BIOVAC

7.7.1. Company overview
7.7.2. Operating business segments
7.7.3. Business performance
7.7.4. Key strategic moves & developments

7.8. MERIAL

7.8.1. Company overview
7.8.2. Operating business segments
7.8.3. Business performance

7.9. ANICON LABOR GMBH

7.9.1. Company overview
7.9.2. Business performance
7.9.3. Key strategic moves & developments

LIST OF TABLES

TABLE 1. GLOBAL ANIMAL VACCINES MARKET, BY PRODUCT TYPE ($MILLION)
TABLE 2. GLOBAL ATTENUATED ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 3. GLOBAL INACTIVATED ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 4. GLOBAL SUBUNIT ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 5. GLOBAL TOXOID ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 6. GLOBAL CONJUGATE ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 7. GLOBAL RECOMBINANT ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 8. GLOBAL DNA ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 9. GLOBAL ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 10. GLOBAL COMPANION ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 11. GLOBAL ANIMAL VACCINES CATTLE MARKET, BY GEOGRAPHY ($MILLION)
TABLE 12. GLOBAL ANIMAL VACCINES PIGS MARKET, BY GEOGRAPHY ($MILLION)
TABLE 13. GLOBAL ANIMAL VACCINES POULTRY MARKET, BY GEOGRAPHY ($MILLION)
TABLE 14. GLOBAL ANIMAL VACCINES SHEEP MARKET, BY GEOGRAPHY ($MILLION)
TABLE 15. GLOBAL ANIMAL VACCINES MARKET, BY GEOGRAPHY ($MILLION)
TABLE 16. NORTH AMERICA ANIMAL VACCINES MARKET, BY PRODUCT ($MILLION)
TABLE 17. NORTH AMERICA VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 18. NORTH AMERICA COMPANION ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 19. NORTH AMERICA ANIMAL VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 20. EUROPE VACCINES MARKET, BY PRODUCT ($MILLION)
TABLE 21. EUROPE VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 22. EUROPE COMPANION ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 23. EUROPE ANIMAL VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 24. ASIA-PACIFIC VACCINES MARKET, BY PRODUCT ($MILLION)
TABLE 25. ASIA-PACIFIC VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 26. ASIA-PACIFIC COMPANION ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 27. ASIA-PACIFIC ANIMAL VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 28. LAMEA VACCINES MARKET, BY PRODUCT ($MILLION)
TABLE 29. LAMEA VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 30. LAMEA COMPANION ANIMAL VACCINES MARKET, BY ANIMAL TYPE ($MILLION)
TABLE 31. LAMEA ANIMAL VACCINES MARKET, BY COUNTRY ($MILLION)
TABLE 32. ROMVAC: COMPANY SNAPSHOT
TABLE 33. ROMVAC: OPERATING SEGMENTS
TABLE 34. VAXXINOVA: COMPANY SNAPSHOT
TABLE 35. VAXXINOVA: OPERATING SEGMENTS
TABLE 36. BIOVAC: COMPANY SNAPSHOT
TABLE 37. BIOVAC: OPERATING SEGMENTS
TABLE 38. MERCK: COMPANY SNAPSHOT
TABLE 39. MERCK: OPERATING SEGMENTS
TABLE 40. ZOETIS: COMPANY SNAPSHOT
TABLE 41. ZOETIS: OPERATING SEGMENTS
TABLE 42. CEVA SANTÉ ANIMALE: COMPANY SNAPSHOT
TABLE 43. CEVA SANTÉ ANIMALE: OPERATING SEGMENTS
TABLE 44. SANOFI: COMPANY SNAPSHOT
TABLE 45. SANOFI: OPERATING SEGMENTS
TABLE 46. MERIAL: COMPANY SNAPSHOT
TABLE 47. MERIAL: OPERATING SEGMENTS
TABLE 48. ANICON LABOR GMBH: COMPANY SNAPSHOT
TABLE 49. ANICON LABOR GMBH: OPERATING SEGMENTS

LIST OF FIGURES

FIGURE 1. GLOBAL ANIMAL VACCINES MARKET: SEGMENTATION
FIGURE 2. TOP INVESTMENT POCKETS: GLOBAL ANIMAL VACCINES MARKET, BY ANIMAL TYPE
FIGURE 3. U.S. ANIMAL VACCINES MARKET, 2014-2022
FIGURE 4. CANADA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 5. MEXICO ANIMAL VACCINES MARKET, 2014-2022
FIGURE 6. GERMANY ANIMAL VACCINES MARKET, 2014-2022
FIGURE 7. FRANCE ANIMAL VACCINES MARKET, 2014-2022
FIGURE 8. UK ANIMAL VACCINES MARKET, 2014-2022
FIGURE 9. ITALY ANIMAL VACCINES MARKET, 2014-2022
FIGURE 10. REST OF EUROPE ANIMAL VACCINES MARKET, 2014-2022
FIGURE 11. JAPAN ANIMAL VACCINES MARKET, 2014-2022
FIGURE 12. CHINA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 13. AUSTRALIA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 14. INDIA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 15. SOUTH KOREA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 16. TAIWAN ANIMAL VACCINES MARKET, 2014-2022
FIGURE 17. REST OF ASIA-PACIFIC ANIMAL VACCINES MARKET, 2014-2022
FIGURE 18. BRAZIL ANIMAL VACCINES MARKET, 2014-2022
FIGURE 19. TURKEY ANIMAL VACCINES MARKET, 2014-2022
FIGURE 20. VENEZEULA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 21. SAUDI ARABIA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 22. LAMEA ANIMAL VACCINES MARKET, 2014-2022
FIGURE 23. ROMVAC: REVENUE, BY YEAR ($MILLION)
FIGURE 24. ROMVAC: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 25. ROMVAC: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 26. VAXXINOVA: REVENUE, BY YEAR ($MILLION)
FIGURE 27. VAXXINOVA: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 28. VAXXINOVA: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 29. BIOVAC: REVENUE, BY YEAR ($MILLION)
FIGURE 30. BIOVAC: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 31. BIOVAC: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 32. MERCK: REVENUE, BY YEAR ($MILLION)
FIGURE 33. MERCK: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 34. MERCK: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 35. ZOETIS: REVENUE, BY YEAR ($MILLION)
FIGURE 36. ZOETIS: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 37. ZOETIS: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 38. CEVA SANTÉ ANIMALE: REVENUE, BY YEAR ($MILLION)
FIGURE 39. CEVA SANTÉ ANIMALE: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 40. CEVA SANTÉ ANIMALE: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 41. SANOFI: REVENUE, BY YEAR ($MILLION)
FIGURE 42. SANOFI: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 43. SANOFI: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 44. MERIAL: REVENUE, BY YEAR ($MILLION)
FIGURE 45. MERIAL: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 46. MERIAL: REVENUE, BY GEOGRAPHY, 2015 (%)
FIGURE 47. ANICON LABOR GMBH: REVENUE, BY YEAR ($MILLION)
FIGURE 48. ANICON LABOR GMBH: REVENUE, BY SEGMENT, 2015 (%)
FIGURE 49. ANICON LABOR GMBH: REVENUE, BY GEOGRAPHY, 2015 (%)

The animal vaccines market is expected to witness moderate growth owing to increase in incidence of various animal diseases such as rabies and Newcastle disease. The demand for animal vaccines is anticipated to increase owing to high nutritional value of animal-derived food products such as meat & milk and rise in need for companion animals. Furthermore, rise in emergence of antibiotic-resistant microorganisms due to high usage of antibiotics among animals is expected to fuel the growth of the global animal vaccines market.

Advancement in production of vaccines is expected to have a positive impact on the market growth. The advancement in the field of molecular biology has increased the production of DNA & recombinant vaccines. Advancement in production of plant-based animal vaccines reduces the production cost and makes the vaccines safer and more stable for usage in animals.

The employment of technologically advanced animal vaccines is highest in North America, owing of the increase in adoption of these products and rise in disposable income. The growth of the market is driven by rise in disposable income, increase in demand for meat in developing countries such as China and India, and growth in adoption of companion animals. The cattle segment significantly contributes toward the market growth owing to the rise in demand for dairy products.

License Type
Data Pack
Single User PDF
Five User Online/PDF
Enterprise Online/PDF
LICENSE INFO
Users/Sharing
Restricted to one authorized user

Restricted to one authorized user

Limited to 5 authorized users


Unlimited within company / enterprise
Printing
One Print only

One Print only
Up to Five Copies
Unlimited within company / enterprise
Delivery Formats
ADDED BENIFITS
20% Free customization (Pre-sale)
16 Analyst hour support (Post Sale)
40 Analyst hour support (Post Sale)
160 hours of mini-consult
Free quarterly industry update
Free report on update (within 180 days)
MULTIPLE PURCHASE
Complimentary report with 2 reports
Complimentary report with 3 reports
Subscription Model
Have questions ?
Speak with analyst
connect
Did you miss anything?
To add more
request

 
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high level data integrity, accurate analysis and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

Targeted Market View

Targeted market view to eliminate redundant information to provide valued information and save time of the reader

 

Featured Readings



May 2017

Vaccines Market- Global Opportunity Analysis and Industry Forecast, 2017-2023



Jul 2016

Liver Disease Treatment Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2022



Feb 2015

Small Animal Imaging (In-Vivo) Market- Global Opportunity Analysis and Industry Forecast, 2013 - 2020



Sep 2014

World Potential Analysis of Ebola drug and Vaccines Market- Opportunities and Forecasts, 2020



Aug 2015

Specialty Enzymes Market- Global Opportunity Analysis and Industry Forecast, 2014 - 2020

Further Readings



Nov 2017

World Therapeutic Vaccines Market- Opportunities and Forecasts, 2017-2023



Nov 2017

Meningococcal Vaccines Market- Global Opportunity Analysis and Industry Forecast, 2017-2023



Nov 2017

World Animal Antimicrobials and Antibiotics Market- Opportunities and Forecasts, 2017-2023



Nov 2017

Equine Healthcare Market- Global Opportunity Analysis and Industry Forecast, 2017-2023



Nov 2017

World DNA Vaccines Market- Opportunities and Forecasts, 2017-2023

 

Get fresh content delivered

Get insights on topics that matter to your business. Stay updated on the areas that interest you.

About
US
Find
HELP
Consulting &
CUSTOM STUDIES
Our
PRODUCTS
Our
SERVICES
Press
MEDIA
STAY WITH US

fb blogger linkedin Gplus twitter Youtube Rss

WE ACCEPT


weAccept